PET scan changed treatment plans for nearly half of patients whose first scan was negative, according to new research ...
An AI-powered biomarker based on histology alone predicted survival among men with metastatic hormone-sensitive prostate cancer and identified those who benefitted from escalation to triplet therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results